• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. GYNECARE MORCELLEX UNKNOWN PRODUCT; LAPARSCOPIC, GYNECOLOGIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. GYNECARE MORCELLEX UNKNOWN PRODUCT; LAPARSCOPIC, GYNECOLOGIC Back to Search Results
Device Problem Other (for use when an appropriate device code cannot be identified) (2203)
Patient Problems Surgical procedure (2357); Iatrogenic Source (2498); Treatment with medication(s) (2571)
Event Date 11/20/2012
Event Type  Injury  
Event Description
It was reported by an attorney that the patient underwent a laparoscopic hysterectomy and bsoo for the treatment of uterine fibroids on (b)(6) 2012 and a morcellator was utilized.No ca was diagnosed prior to surgery.The pathology revealed endometrial adenocarcinoma.The patient has undergone treatment , including chemotherapy.
 
Manufacturer Narrative
(b)(4).Conclusion: the device information for use under precautions states" caution: the use of a laparoscopic tissue extraction bag is recommended for the morcellation of malignant tissue or tissue suspected of being malignant and for tissue that the physician considers to be potentially harmful when disseminated in a body cavity.As morcellation may affect endometrial pathologic examination, preoperative evaluation of the endometrium should be considered.Should malignancy be identified, use of the gynecare morcellex¿ tissue morcellator may lead to dissemination of malignant tissue.
 
Manufacturer Narrative
Additional narrative: it was reported that the patient had a laparoscopic supracervical hysterectomy, bso, cystoscopy and enterolysis of adhesions on (b)(6) 2012 and mesh was utilized.Pathology showed endometrioid adenocarcinoma.She had a complete surgical debulking on (b)(6) 2013 and was treated with chemotherapy in (b)(6) 2015.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GYNECARE MORCELLEX UNKNOWN PRODUCT
Type of Device
LAPARSCOPIC, GYNECOLOGIC
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
Manufacturer (Section G)
MEDTECH GROUP INC
6 century ln
south plainfield NJ 07080
Manufacturer Contact
mary szaro
9082183464
MDR Report Key4836204
MDR Text Key5909842
Report Number2210968-2015-06955
Device Sequence Number1
Product Code HET
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K100280
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,other
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 06/06/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/10/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received01/29/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age50 YR
Patient Weight97
-
-